Some Investing Thoughts On Windtree Therapeutics Inc (NASDAQ: WINT)

Windtree Therapeutics Inc (WINT) concluded trading on Thursday at a closing price of $0.34, with 7.71 million shares of worth about $2.62 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -89.37% during that period and on Thursday the price saw a loss of about -2.95%. Currently the company’s common shares owned by public are about 8.99M shares, out of which, 8.94M shares are available for trading.

Stock saw a price change of 11.59% in past 5 days and over the past one month there was a price change of -37.62%. Year-to-date (YTD), WINT shares are showing a performance of -2.95% which decreased to -97.30% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.29 but also hit the highest price of $14.75 during that period. The average intraday trading volume for Windtree Therapeutics Inc shares is 1.75 million. The stock is currently trading -3.58% below its 20-day simple moving average (SMA20), while that difference is down -34.97% for SMA50 and it goes to -91.25% lower than SMA200.

Windtree Therapeutics Inc (NASDAQ: WINT) currently have 8.99M outstanding shares and institutions hold larger chunk of about 1.81% of that.

The stock has a current market capitalization of $3.05M and its 3Y-monthly beta is at 0.57. It has posted earnings per share of -$18.63 in the same period. It has Quick Ratio of 0.27 while making debt-to-equity ratio of 1.68. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for WINT, volatility over the week remained 13.62% while standing at 11.70% over the month.

Stock’s fiscal year EPS is expected to rise by 94.00% while it is estimated to increase by 49.47% in next year.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Ladenburg Thalmann on June 26, 2020 offering a Buy rating for the stock and assigned a target price of $12.25 to it.

Most Popular

Related Posts